Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer N Jin, A Bi, X Lan, J Xu, X Wang, Y Liu, T Wang, S Tang, H Zeng, Z Chen, ... Nature Communications 10 (1), 2701, 2019 | 97 | 2019 |
Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors X Liang, S Tang, X Liu, Y Liu, Q Xu, X Wang, A Saidahmatov, C Li, ... Journal of medicinal chemistry 65 (2), 1243-1264, 2021 | 45 | 2021 |
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies Z Liu, Y Liu, L Qian, S Jiang, X Gai, S Ye, Y Chen, X Wang, L Zhai, J Xu, ... Molecular Cell 81 (19), 4076-4090. e8, 2021 | 41 | 2021 |
SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors X Wang, Z Chen, J Xu, S Tang, N An, L Jiang, Y Zhang, S Zhang, Q Zhang, ... Cell research 32 (7), 638-658, 2022 | 31 | 2022 |
Magnesium lithospermate B protects the endothelium from inflammation-induced dysfunction through activation of Nrf2 pathway F Gao, J Li, C Xi, H Li, Y Liu, Y Wang, L Xuan Acta Pharmacologica Sinica 40 (7), 867-878, 2019 | 22 | 2019 |
Magnesium lithospermate B ameliorates microcirculation perfusion in rats by promoting vascular NO production via activating the PI3K/AKT pathway Y Liu, X Zhou, L Xuan Acta Pharmacologica Sinica 40 (8), 1010-1018, 2019 | 14 | 2019 |
Investigation of the affordability of chronic diseases drug use in families from three provinces in Western China F Liu, Y Liu, Q Chen, Y WU, C Zhang, S Pan, M HU Chinese Journal of Health Policy, 54-58, 2017 | 4 | 2017 |
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer X Gai, Y Liu, X Lan, L Chen, T Yuan, J Xu, Y Li, Y Zheng, Y Yan, L Yang, ... Cancer Research 84 (12), 1963-1977, 2024 | 3 | 2024 |
A proteomic landscape of pharmacologic perturbations for functional relevance Z Liu, S Jiang, B Hao, S Xie, Y Liu, Y Huang, H Xu, C Luo, M Huang, ... Journal of Pharmaceutical Analysis 14 (1), 128-139, 2024 | 1 | 2024 |
Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by loss of oncoproteins in hepatocytes X Wang, J Zhang, Y Liu, S Zhang, Y Liang, M Zong, X Lin, M Karin, ... Cancer Research 84 (6_Supplement), 2274-2274, 2024 | | 2024 |
Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells C Pu, Y Li, Y Fu, Y Yan, S Tao, S Tang, X Gai, Z Ding, Z Gan, Y Liu, S Cao, ... Advanced Science 11 (11), 2304781, 2024 | | 2024 |
Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by oncoprotein loss X Wang, Y Liu, S Zhang, J Zhang, X Lin, Y Liang, M Zong, KL Hanley, ... Hepatology, 10.1097, 2024 | | 2024 |
NCOA5 Deficiency in Macrophages Provokes NASH and HCC Y Liu, GS Feng Cellular and Molecular Gastroenterology and Hepatology 17 (1), 171-172, 2024 | | 2024 |